Flurbiprofen Sodium API

Name	Flurbiprofen sodium
Chinese name	氟比洛芬钠
Cas Number	-
Source	India
Qualifications	-/-/-/-/-

The raw material of flurbiprofen sodium is produced by Bausch & Lomb of the United States and listed in the United States in 1995. Its eye drops formulations are developed and produced by the United States Eye Life. The mechanism of flurbiprofen sodium is mainly to inhibit the activity of cyclooxygenase (COX), block the synthesis of prostaglandins, and relieve inflammation. Clinical research results of intraocular lens implantation showed that compared with the use of compound tropinamide eye drops (62.5%), the proportion of pupils of flurbiprofen sodium at grade 2 or higher was 10.7%; In the observation of the reaction, the proportion of flurbiprofen sodium inflammatory reaction above grade 2 was 14.3%, and the proportion of using compound tropinamide eye drops was 58.3%, so it is determined that the preventive and protective treatment of patients with senile cataract surgery It is safer to choose non-steroidal anti-inflammatory drugs such as flurbiprofen sodium. Flurbiprofen sodium provides a new, safe and effective way for the treatment of internal eye surgery and even traumatic inflammation of the eye.

Hot Tags: flurbiprofen sodium api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Edoxaban API, Adapalene API, Lifitegrast API, Aprepitant Aprepitant API, Troxagliptin Succinate API, Ranolazine API

• Previous: Dinoprostone API
• Next: Benzoyl Metronidazole API